2026年全球分子診斷（基於次世代定序（NGS））市場報告

近年來，基於次世代定序（NGS）的分子診斷市場呈現顯著成長，預計將從2025年的22.6億美元成長到2026年的24.3億美元，複合年成長率（CAGR）為7.6%。過去幾年的成長可歸因於多種因素，例如遺傳疾病檢測的增加、高通量定序技術的進步、人們對分子診斷認知的提高、分子診斷技術在臨床檢查室的廣泛應用以及定序試劑的技術進步。

基於次世代定序（NGS）的分子診斷市場預計將在未來幾年強勁成長，到2030年達到32.3億美元，複合年成長率（CAGR）為7.3%。預測期內的成長要素包括人工智慧和機器學習在診斷領域的應用、雲端基因組學平台的擴展、攜帶式和照護現場定序的開發、個人化醫療的日益普及以及診斷公司與生物技術公司之間的合作。預測期內的關鍵趨勢包括人工智慧輔助分子診斷、雲端基因組學平台、攜帶式定序設備、生物資訊流程整合以及疾病標記的快速檢測。

預計未來幾年，感染疾病率的上升將推動基於次世代定序（NGS）技術的分子診斷市場發展。感染疾病是由細菌、病毒、真菌和寄生蟲等微生物引起的，這些微生物侵入人體並在體內繁殖，破壞正常生理功能。全球旅行和人口流動的增加促進了病原體在不同地區和國界之間的傳播，導致感染疾病病例增加。基於NGS的分子診斷技術透過對病原體進行全面、精準的分析，能夠同時識別多種微生物，從而幫助檢測這些疾病。這縮短了診斷時間，提高了治療的準確性和患者照護。例如，根據英國衛生安全局2024年2月發布的報告，英格蘭的結核病病例數增加了10.7%，從2022年的4,380例增加到2023年的4,850例。感染疾病率的上升正在推動對基於次世代定序（NGS）技術的分子診斷技術的需求。

在基於次世代定序(NGS) 的分子診斷市場中，主要企業正致力於開發先進的 NGS 檢測panel，以提高基因檢測的準確性、可近性和效率。 NGS panel 是一組標靶基因或基因組區域，利用 NGS 技術同時進行分析，以識別具有臨床意義的突變，從而實現更快、更準確的分子診斷。例如，2024 年 4 月，美國診斷公司 Pillar Biosciences 的 oncoReveal CDx 泛癌實體瘤體外診斷試劑盒獲得 FDA核准，該試劑盒可在單次多重反應中檢測 22 個具有臨床意義的基因。該 panel 專為 Illumina MiSeq 檢體系統設計，從檢體到報告大約需要 48 小時，單次運行最多可處理 46 個臨床檢體。 Oncorevir CDx 包括 KRAS（用於結直腸癌的 EGFR標靶治療）和 EGFR（用於非小細胞肺癌的 TKI 治療）的伴隨診斷索賠，透過更全面、更有效地檢測可操作的基因組改變，有助於改善臨床決策。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球次世代定序（NGS）分子診斷市場：吸引力評分與分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 人工智慧（AI）和自主人工智慧
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
  • 物聯網、智慧基礎設施和互聯生態系統
• 主要趨勢
  • 人工智慧輔助分子診斷
  • 雲基因組分析平台
  • 攜帶式定序儀
  • 生物資訊流程整合
  • 快速檢測疾病標記

第5章 終端用戶產業市場分析

• 研究中心和學術機構
• 醫院和臨床檢查室
• 生物製藥公司
• 基因檢測實驗室
• 合約研究組織（CRO）

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球次世代定序（NGS）分子診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 全球次世代定序（NGS）分子診斷市場規模、比較及成長率分析
• 全球次世代定序（NGS）分子診斷市場表現：規模與成長，2020-2025年
• 全球次世代定序(NGS) 分子診斷市場預測：規模與成長，2025-2030 年，2035 年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 按類型
• 儀器、試劑及耗材、軟體及服務、檢測板及分析、樣品製備試劑盒
• 透過使用
• 微生物學、感染疾病、腫瘤學、基因檢測及其他應用領域
• 最終用戶
• 研究機構、學術機構、醫院、臨床檢查室和其他最終用戶
• 按類型細分：設備
• 桌上型定序儀、高通量定序儀、可攜式或手持式定序儀、臨床或診斷定序儀、自動化樣品製備系統、數據分析和生物資訊硬體
• 按類型細分：試劑和耗材
• 定序試劑和試劑盒、樣品製備試劑、標靶富集試劑、擴增試劑、定序流動池和晶片、去氧核糖核酸(DNA) 或核糖核酸 (RNA) 萃取試劑、品管試劑
• 按類型細分：軟體和服務
• 數據分析軟體、生物資訊學流程、基於雲端的基因組平台、臨床解讀工具、數據儲存和管理服務、客製化生物資訊服務、基因組資料庫服務
• 按類型細分：檢測板和檢測方法
• 腫瘤檢測組合、感染疾病組合、帶因者篩檢組合、生殖健康檢測組合、罕見疾病或遺傳疾病檢測組合、藥物基因體學檢測組合、全EXOME組或全基因組檢測
• 按類型細分：樣本製備試劑盒
• 去氧核糖核酸(DNA) 萃取試劑盒、核糖核酸 (RNA) 萃取試劑盒、樣品製備盒、標靶富集試劑盒、擴增純化試劑盒、單細胞製備試劑盒、低豐度或劣化試劑盒

第10章 區域與國家分析

• 全球次世代定序(NGS) 分子診斷市場：按地區分類，實際結果與預測，2020-2025 年、2025-2030 年預測、2035 年預測
• 全球次世代定序(NGS) 分子診斷市場：國家/地區、績效與預測，2020-2025 年、2025-2030 年預測、2035 年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 次世代定序（NGS）分子診斷市場：競爭格局與市場佔有率，2024年
• 次世代定序（NGS）分子診斷市場：公司估值矩陣
• 次世代定序（NGS）分子診斷市場：公司概況
  • Thermo Fisher Scientific
  • Siemens Healthineers AG
  • Agilent Technologies Inc.
  • Illumina Inc.
  • PerkinElmer Inc.

第37章：其他領先和創新企業

• Bio-Rad Laboratories Inc., Qiagen NV, Amoy Diagnostics Co. Ltd., Tempus Labs Inc., Myriad Genetics Inc., Epigenomics AG, Precision for Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Caris Life Sciences Inc., Foundation Medicine Inc., Oxford Nanopore Technologies Ltd., Freenome Inc., Burning Rock Biotech

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年次世代定序（NGS）分子診斷市場：提供新機會的國家
• 2030年次世代定序（NGS）分子診斷市場：充滿新機會的細分市場
• 2030年次世代定序（NGS）分子診斷市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Next-generation sequencing (NGS)-based molecular diagnostics is a technology-driven approach that uses high-throughput sequencing to analyze genetic material with precision and speed. It enables detection of genetic variations, mutations, and disease markers at the molecular level, providing detailed insights into the genetic basis of health and disease. This approach supports precise, data-driven diagnostics by combining sequencing technologies with advanced bioinformatics.

The primary types of NGS-based molecular diagnostics include instruments, reagents and consumables, software and services, panels and assays, and sample preparation kits. NGS instruments are the hardware platforms, such as sequencers and automation workstations, used to perform high-throughput DNA/RNA sequencing. Applications include microbiology, infectious diseases, oncology, genetic testing, and other areas. End users include research centers, academic institutions, hospitals, clinical laboratories, and other organizations.

Tariffs have influenced the NGS-based molecular diagnostics market by raising the cost of imported instruments, sequencing kits, and bioinformatics software. Hospitals, research labs, and diagnostic centers are most affected, particularly in Asia-Pacific and Europe. Segments like high-throughput sequencers and library preparation kits face increased costs. Positive outcomes include promotion of local manufacturing and domestic software development, which enhances supply chain resilience and innovation.

The next-generation sequencing (ngs)-based molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides next-generation sequencing (ngs)-based molecular diagnostics market statistics, including next-generation sequencing (ngs)-based molecular diagnostics industry global market size, regional shares, competitors with a next-generation sequencing (ngs)-based molecular diagnostics market share, detailed next-generation sequencing (ngs)-based molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation sequencing (ngs)-based molecular diagnostics industry. This next-generation sequencing (ngs)-based molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The next-generation sequencing (ngs)-based molecular diagnostics market size has grown strongly in recent years. It will grow from $2.26 billion in 2025 to $2.43 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to growth in genetic disorder testing, development of high-throughput sequencing, rising awareness of molecular diagnostics, adoption in clinical labs, technological improvements in sequencing reagents.

The next-generation sequencing (ngs)-based molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.23 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to integration of ai and machine learning in diagnostics, expansion of cloud-based genomic platforms, development of portable and point-of-care sequencing devices, rise in personalized medicine applications, collaborations between diagnostics and biotech firms. Major trends in the forecast period include AI-assisted molecular diagnostics, cloud genomic analysis platforms, portable sequencing devices, integration of bioinformatics pipelines, rapid disease marker detection.

The rising incidence of infectious diseases is expected to drive growth in the next-generation sequencing (NGS)-based molecular diagnostics market in the coming years. Infectious diseases are illnesses caused by microorganisms such as bacteria, viruses, fungi, or parasites that invade and multiply within the body, disrupting normal functions. Increasing global travel and migration contribute to the spread of pathogens across regions and borders, fueling the rise in infectious disease cases. NGS-based molecular diagnostics aids in detecting these diseases by offering comprehensive and precise analysis of pathogens, enabling simultaneous identification of multiple microorganisms, which shortens diagnostic time and improves treatment accuracy and patient care. For example, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England increased by 10.7%, rising from 4,380 in 2022 to 4,850 in 2023. Consequently, the growing incidence of infectious diseases is propelling the demand for NGS-based molecular diagnostics.

Major companies operating in the next-generation sequencing (NGS)-based molecular diagnostics market are concentrating on developing advanced NGS-based panels to improve the accuracy, accessibility, and efficiency of genetic testing. NGS panels are targeted collections of genes or genomic regions analyzed simultaneously using NGS technology to identify clinically relevant mutations, enabling faster and more precise molecular diagnostics. For example, in April 2024, Pillar Biosciences, a US-based diagnostics company, received FDA approval for its oncoReveal CDx pan-cancer solid tumor IVD kit, which examines 22 clinically relevant genes in a single multiplex reaction. Designed for use with Illumina's MiSeq Dx system, the panel offers a sample-to-report time of around 48 hours and can process up to 46 clinical samples per run. OncoReveal CDx includes companion diagnostic claims for KRAS (for EGFR-targeted therapy in colorectal cancer) and EGFR (for TKI therapy in non-small-cell lung cancer), allowing more comprehensive and efficient detection of actionable genomic alterations to enhance clinical decision-making.

In January 2023, QIAGEN NV, a molecular diagnostics and life sciences company based in Germany, acquired Verogen Inc. for an undisclosed sum. This acquisition aims to enhance QIAGEN's leadership in human identification and forensic genomics by integrating Verogen's specialized NGS technologies into its broader molecular diagnostics portfolio. This expansion strengthens QIAGEN's presence in public sector forensics and private sector applications such as genetic genealogy. Verogen Inc. is a US-based company specializing in NGS solutions for forensic genomics.

Major companies operating in the next-generation sequencing (ngs)-based molecular diagnostics market are Thermo Fisher Scientific, Siemens Healthineers AG, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Amoy Diagnostics Co. Ltd., Tempus Labs Inc., Myriad Genetics Inc., Epigenomics AG, Precision for Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Caris Life Sciences Inc., Foundation Medicine Inc., Oxford Nanopore Technologies Ltd., Freenome Inc., Burning Rock Biotech, Element Biosciences Inc., Asuragen Inc., Bionano Genomics Inc., Genomic Health Inc., TATAA Biocenter AB

North America was the largest region in the next-generation sequencing (NGS)-based molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation sequencing (ngs)-based molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the next-generation sequencing (ngs)-based molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The next-generation sequencing (NGS)-based molecular diagnostics market includes revenues earned by entities by providing services, such as clinical genomic testing, cancer genomic profiling, infectious disease detection, liquid biopsy testing, and pharmacogenomics testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation sequencing (NGS)-based molecular diagnostics market also includes sales of tumor mutation panels, carrier screening kits, drug response panels, companion diagnostic kits, and whole-genome metagenomics kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses next-generation sequencing (ngs)-based molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for next-generation sequencing (ngs)-based molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The next-generation sequencing (ngs)-based molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Instruments; Reagents And Consumables; Software And Services; Panels And Assays; Sample Preparation Kits
• 2) By Application: Microbiology; Infectious Diseases; Oncology; Genetic Tests; Other Applications
• 3) By End User: Research Centers And Academics; Hospitals And Clinical Laboratories; Other End Users
• Subsegments:
• 1) By Instruments: Benchtop Sequencers; High-Throughput Sequencers; Portable Or Handheld Sequencers; Clinical Or Diagnostic Sequencers; Automated Library Preparation Systems; Data Analysis And Bioinformatics Hardware
• 2) By Reagents And Consumables: Sequencing Reagents And Kits; Library Preparation Reagents; Target Enrichment Reagents; Amplification Reagents; Sequencing Flow Cells And Chips; Deoxyribonucleic Acid (DNA) Or Ribonucleic Acid (RNA) Extraction Reagents; Quality Control Reagents
• 3) By Software And Services: Data Analysis Software; Bioinformatics Pipelines; Cloud-Based Genomic Platforms; Clinical Interpretation Tools; Data Storage And Management Services; Custom Bioinformatics Services; Genomic Database Services
• 4) By Panels And Assays: Oncology Panels; Infectious Disease Panels; Carrier Screening Panels; Reproductive Health Panels; Rare Disease Or Genetic Disorder Panels; Pharmacogenomics Panels; Whole-Exome Or Whole-Genome Assays
• 5) By Sample Preparation Kits: Deoxyribonucleic Acid (DNA) Extraction Kits; Ribonucleic Acid (RNA) Extraction Kits; Library Preparation Kits; Target Enrichment Kits; Amplification And Cleanup Kits; Single-Cell Preparation Kits; Low-Input Or Degraded Sample Kits
• Companies Mentioned: Thermo Fisher Scientific; Siemens Healthineers AG; Agilent Technologies Inc.; Illumina Inc.; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Qiagen N.V.; Amoy Diagnostics Co. Ltd.; Tempus Labs Inc.; Myriad Genetics Inc.; Epigenomics AG; Precision for Medicine Inc.; Invitae Corporation; NeoGenomics Laboratories Inc.; Guardant Health Inc.; Caris Life Sciences Inc.; Foundation Medicine Inc.; Oxford Nanopore Technologies Ltd.; Freenome Inc.; Burning Rock Biotech; Element Biosciences Inc.; Asuragen Inc.; Bionano Genomics Inc.; Genomic Health Inc.; TATAA Biocenter AB
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Ai-Assisted Molecular Diagnostics
  • 4.2.2 Cloud Genomic Analysis Platforms
  • 4.2.3 Portable Sequencing Devices
  • 4.2.4 Integration Of Bioinformatics Pipelines
  • 4.2.5 Rapid Disease Marker Detection

5. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Analysis Of End Use Industries

• 5.1 Research Centers And Academic Institutes
• 5.2 Hospitals And Clinical Laboratories
• 5.3 Biopharmaceutical Companies
• 5.4 Genetic Testing Laboratories
• 5.5 Contract Research Organizations (Cros)

6. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Segmentation

• 9.1. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Instruments, Reagents And Consumables, Software And Services, Panels And Assays, Sample Preparation Kits
• 9.2. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Microbiology, Infectious Diseases, Oncology, Genetic Tests, Other Applications
• 9.3. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Research Centers And Academics, Hospitals And Clinical Laboratories, Other End Users
• 9.4. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Benchtop Sequencers, High-Throughput Sequencers, Portable Or Handheld Sequencers, Clinical Or Diagnostic Sequencers, Automated Library Preparation Systems, Data Analysis And Bioinformatics Hardware
• 9.5. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sequencing Reagents And Kits, Library Preparation Reagents, Target Enrichment Reagents, Amplification Reagents, Sequencing Flow Cells And Chips, Deoxyribonucleic Acid (DNA) Or Ribonucleic Acid (RNA) Extraction Reagents, Quality Control Reagents
• 9.6. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Data Analysis Software, Bioinformatics Pipelines, Cloud-Based Genomic Platforms, Clinical Interpretation Tools, Data Storage And Management Services, Custom Bioinformatics Services, Genomic Database Services
• 9.7. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Panels And Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oncology Panels, Infectious Disease Panels, Carrier Screening Panels, Reproductive Health Panels, Rare Disease Or Genetic Disorder Panels, Pharmacogenomics Panels, Whole-Exome Or Whole-Genome Assays
• 9.8. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Sample Preparation Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Deoxyribonucleic Acid (DNA) Extraction Kits, Ribonucleic Acid (RNA) Extraction Kits, Library Preparation Kits, Target Enrichment Kits, Amplification And Cleanup Kits, Single-Cell Preparation Kits, Low-Input Or Degraded Sample Kits

10. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Regional And Country Analysis

• 10.1. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 11.1. Asia-Pacific Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 12.1. China Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 13.1. India Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 14.1. Japan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 15.1. Australia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 16.1. Indonesia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 17.1. South Korea Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 18.1. Taiwan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 19.1. South East Asia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 20.1. Western Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 21.1. UK Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 22.1. Germany Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 23.1. France Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 24.1. Italy Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 25.1. Spain Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 26.1. Eastern Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 27.1. Russia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 28.1. North America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 29.1. USA Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 30.1. Canada Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 31.1. South America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 32.1. Brazil Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 33.1. Middle East Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

• 34.1. Africa Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Regulatory and Investment Landscape

36. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Competitive Landscape And Company Profiles

• 36.1. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Other Major And Innovative Companies

• Bio-Rad Laboratories Inc., Qiagen N.V., Amoy Diagnostics Co. Ltd., Tempus Labs Inc., Myriad Genetics Inc., Epigenomics AG, Precision for Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Caris Life Sciences Inc., Foundation Medicine Inc., Oxford Nanopore Technologies Ltd., Freenome Inc., Burning Rock Biotech

38. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

40. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market High Potential Countries, Segments and Strategies

• 40.1 Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer